Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...
Threat actors abused trusted Trivy distribution channels to inject credential‑stealing malware into CI/CD pipelines worldwide ...
The weird, rare, surprising patterns that make data rich slowly get smoothed out when an AI model trains on outputs from a ...
Stop piping grep into five other commands. It already handles most of that.
Making a mistake, or just being accused of one, can create legal problems. Errors and omissions insurance may help. Many, or all, of the products featured on this page are from our advertising ...